Ireland Pacemaker Market By Type (Implantable, External), By Technology (Single Chamber, Dual Chamber, Biventricular Chamber), By Product Type (Conventional, MRI Compatible), By Application (Arrhythmias, Congestive Heart Failure, Others), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers), By Region, Competition Forecast & Opportunities, 2028

The Ireland Pacemaker Market is expected to grow at an impressive rate during the forecast period, 2024-2028. This is attributed to the increase in the prevalence of chronic diseases such as cardiovascular diseases, cardiac arrest, etc., the rise in the aging population, technological advancements, and an increase in healthcare investment. Additionally, the rise in awareness about heart health and the availability of innovative pacemaker devices are contributing to the growth of the Ireland Pacemaker Market.

A pacemaker is a medical device consisting of a generator and wires (leads or electrodes) that can be placed inside the human body, usually by surgery, to support the electrical beat of the heart. It is also used to prevent heart conditions when the heartbeat is too low. Normal aging may disrupt the electrical activity of heart, causing it to beat too slowly, or damage to the heart muscle from a heart attack can disrupt the pace of heartbeat. Sometimes, medication can slow the heart rate. As the number of people with cardiovascular diseases continues to increase, the demand for pacemakers has also been rising. Furthermore, the two main components of the pacemaker are the lead and the generator. The battery and a tiny computer are installed in the pulse generator, which is located just beneath the skin of the chest.

The leads are wires that are implanted into the heart's muscles after being inserted through the veins. They sense the electrical activity of the heart as well as transmit impulses from the pulse generator to the heart muscle. The heart contracts with each impulse. Many different types of permanent pacemakers are also available; some are made to regulate the heart at different rates depending on the type of activity a person is engaged in. These "smart" pacemakers can speed up the heart, for instance, when a person is running for a bus, but will slow it down again when they are at rest. This is more similar to how normal heart functions. Other pacemakers can help the right and left sides of the heartbeat in synchrony, as in CRT (Cardiac Resynchronization Therapy), which involves the placement of a third wire/lead inside the skin. Depending on the kind of pacemaker required to treat your heart condition, the pacemaker could have one to three leads.

Cardiovascular Disease (CVD) is one of the leading causes of death and disability in Ireland. According to the Irish Heart Foundation, approximately 9,000 people die each year from cardiovascular disease, including coronary heart disease, stroke, and other circulatory diseases. The Irish Heart Foundation is working to deliver services that will contribute to a 25% reduction in premature deaths from cardiovascular disease by 2025. To achieve this, they are emphasizing action on stroke, obesity, tobacco control, cardiovascular disease prevention, and heart failure as their policy priorities. Cardiovascular diseases cause extensive morbidity and mortality in Ireland and impose a heavy burden on the healthcare system.

Additionally, another important factor influencing the growth of the Ireland Pacemaker Market is the rising demand for pacemaker implantations that are painless for patients and only require minimally invasive procedures, thereby contributing to the growth of the Ireland Pacemaker Market.

Rising Prevalence of Cardiac Diseases

The increasing prevalence of cardiac disorders in Ireland is directly boosting to the growth of the Ireland pacemaker market. As the incidence of cardiac disorders such as atrial fibrillation, heart failure, and bradycardia increases, the demand for pacemakers also increases.

As the prevalence of cardiac disorders increases in Ireland, more patients require pacemakers as a treatment option. This has led to an increasing demand for pacemakers in the country. In addition, advancements in technology have led to the development of smaller and more efficient pacemakers, which have further increased the adoption of these devices. This will further lead to the growth of Ireland pacemaker market. For instance, according to a research article, there is a 2% prevalence of symptomatic heart failure in the Irish population (rising to 10% in those over 75 years). Additionally, a further 2% have asymptomatic left ventricular systolic dysfunction, putting them at risk of progressing to symptomatic failure. Over 10,000 new cases are diagnosed annually. The problems such as swollen ankles, breathlessness and extreme tiredness are key symptoms of heart failure, a chronic condition affecting 90,000 people living in Ireland and responsible for 20,000 hospital admissions each year. Cardiac conditions can cause disruptions in the heart’s electrical system, leading to an irregular heartbeat or a complete blockage of the heart's electrical signals. Heart disease is the second cause of mortality (after cancer) and in recent years accounted for 15% of the total number of deaths.

According to an article published in Irish Health Foundation, in Ireland, 1 in 4 women in Ireland die from heart disease and stroke with women six times more likely to die from cardiovascular disease than breast cancer. Coupled with the high numbers of women found to be overweight or obese (52%) and with higher-than-normal blood pressure (26.9%), there is a real danger that women are not taking as much care of their hearts as they should.

Additionally, a pacemaker is necessary for several heart disorders, including bradycardia, arrhythmias, ventricular fibrillation, ventricular tachycardia, and heart failure. The prevalence of cardiac arrhythmia is attributed to factors including lifestyle problems, excessive alcohol use, smoking, and obesity, which are predicted to boost the expansion of the Israeli pacemaker market. In Israel, rising lifestyle problems like obesity are widespread and play a significant role in the rise of cardiovascular diseases. This is thereby one of the important factors responsible to propel the growth of Ireland Pacemaker market in the forecast period.

Increasing Aging Population

The increasing prevalence of cardiac disorders in Ireland is a major driving factor for the growth of the pacemaker market in the country. With an aging population and increasing awareness about the importance of cardiac health, the demand for pacemakers is expected to continue to grow in the coming years. This presents an opportunity for pacemaker manufacturers to develop more advanced and innovative devices to meet the growing demand in Ireland. According to a research article, it is estimated that up to 2% of the adult population in developed countries has heart failure, with the prevalence rising to >10% among those aged > 70 years. Because it is primarily a condition of older adults, mortality and morbidity remain high with cardiac attack, despite advances in diagnosis and therapy. Heart failure accounts for 5% of all emergency medical admissions, of which 80% are patients > 65 years of age. With the rise in the aged population around the world, the demand for pacemakers is expected to increase further. This is due to the risk of developing cardiovascular diseases increasing with age. Cardiovascular diseases (CAD) are particularly prevalent among the aging population in Ireland due to the high prevalence of risk factors such as hypertension, diabetes, and smoking. Among the geriatric population, factors such as smoking include a higher risk for cardiovascular diseases and thus indirectly increase the demand for pacemakers.

Generally, people above the age of 65 or 70 years of age have a high demand for pacemakers. This is due to the physiological changes one undergoes during the aging process in which the heart's conduction system becomes disordered. Additionally, as the elderly population increases, there is a greater demand for healthcare services, including long-term care and specialized geriatric care. Furthermore, there may be an increased burden on the social security system, as the elderly population may require additional financial support.

Technological Advancement

Advancements in technology are a key driving factor for the growth of the pacemaker market in Ireland. Over the years, there have been significant advancements in the technology used in pacemakers, leading to the development of smaller, more efficient, and more advanced devices. One major advancement in pacemaker technology has been the development of smaller devices. Smaller pacemakers can be implanted using minimally invasive techniques, reducing the risk of complications and improving patient outcomes. Many modern pacemakers are equipped with advanced sensors that can detect changes in a patient's heart rate and adjust pacing accordingly. This can improve patient outcomes and reduce the risk of complications. The advancements in technology have significantly improved the functionality and reliability of pacemakers, making them a more attractive treatment option for patients in Ireland. As a result, the demand for pacemakers in Ireland is expected to continue to grow in the coming years. Furthermore, the continued development of advanced technologies is likely to further drive the growth of the pacemaker market in Ireland.

Download Free Sample Report

Market Segmentation

The Ireland Pacemaker Market can be segmented by type, technology, product type, application, end user, region and competitive landscape. Based on type, the market is segmented into implantable and external. Based on technology, the market is segmented into conventional, and MRI Compatible. Depending on the Product type, the market is fragmented into arrhythmias, congestive heart failure and others. Based on the end user the market is further divided into hospitals, cardiac care centers and ambulatory surgical centers.

Market Players

Medtronic Ireland Ltd, Abbott Ireland Limited, Boston Scientific Ireland Ltd, Cook Group (Ireland), LivaNova Ireland Limited, and Integer Ireland Medical Ltd etc. are some of the leading companies operating in the market.

Report Scope:

In this report, Ireland Pacemaker Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Ireland Pacemaker Market, By Type

o   Implantable

o   External

• Ireland Pacemaker Market, By Technology

o   Single Chamber

o   Dual Chamber

o   Biventricular Chamber

• Ireland Pacemaker Market, By Product Type

o   Conventional

o   MRI Compatible

• Ireland Pacemaker Market, By Application

o   Arrhythmias

o   Congestive Heart Failure

o   Others

• Ireland Pacemaker Market, By End User

o   Hospitals

o   Cardiac Care Centers

o   Ambulatory Surgical Centers

• Ireland Pacemaker Market, By Region:

o   Northern Ireland

o   North-West

o   West

o   Midland East

o   Dublin

o   Shannon

o   South-East

o   Cork-Kerry

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Ireland Pacemaker Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Ireland Pacemaker Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]